Furthermore, pretreatment of tumor cells with TGF-β1 induced resistance to the chemotherapeutic drug cisplatin in pancreatic cancer, which was mainly mediated by PKCα and P-gp. This evidence concerns the gene PRKCA and familial pancreatic carcinoma.